Protagonist Therapeutics, Inc.
(PTGX - NASDAQ)
99,62 USD
📋 Profilo Aziendale

Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases.

|